PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8406424

Endocarditis caused by Rochalimaea henselae.

T L Hadfield·R Warren·M Kass·E Brun·C Levy
View original source ↗Export metadata ↓

Abstract

A case of community-acquired, culture-negative, infective endocarditis was diagnosed in a 57-year-old construction worker. Small, pleomorphic gram-negative rods were seen in Brown-Hopps tissue gram stains and Warthin-Starry silver stains. The organism was identified as Rochalimaea henselae by polymerase chain reaction amplification and sequencing of the 16S rDNA gene sequence. This is the first report of infective endocarditis caused by R henselae.

Explore related subjects

Community-Acquired InfectionsDNA, BacterialEndocarditis, BacterialGram-Negative BacteriaHumansMaleMiddle AgedSequence Analysis, DNACase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T L Hadfield, R Warren, M Kass, E Brun, C Levy. 1993. Endocarditis caused by Rochalimaea henselae.. https://doi.org/10.1016/0046-8177(93)90196-n

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

CTX-M: changing the face of ESBLs in Europe.

Since around 2000 - earlier in Poland and Spain and later in France and the UK - dramatic shifts have occurred in the prevalence and types of extended-spectrum beta-lactamases (ESBLs) in Europe. Before this watershed, most producers were nosocomial isolates, often Klebsiella spp. or Enterobacter spp. from specialist care units, and had mutant TEM or SHV ESBLs. Subsequently, CTX-M ESBLs have become dominant, with much greater penetration into Escherichia coli, and with many infections in 'complicated community' patients, usually with underlying disease, recent antibiotic usage, or healthcare contact. The degree of clonality among producers varies with the country, as does the enzyme type produced, with group 9 (CTX-M-9 and -14) enzymes dominant in Spain and group 1 enzymes (particularly CTX-M-3 and -15) dominant elsewhere. Irrespective of the particular enzyme, most producers are multiresistant. These changing patterns present major therapeutic and infection control challenges, with the public health intervention points unclear.

Community-Acquired Infections↗